Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

Lynx1 Capital Management LP Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
06/02/2023 4 Lynx1 Capital Management LP (10% Owner) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Sold 10,000 shares @ $2.5148, valued at $25.1k
Sold 15,000 shares @ $2.5201, valued at $37.8k
Sold 400 shares @ $2.5075, valued at $1k
06/02/2023 3 Lynx1 Capital Management LP (10% Owner) has filed a Form 3 on TScan Therapeutics, Inc.
06/02/2023 SC 13G Lynx1 Capital Management LP reports a 12.2% stake in TScan Therapeutics, Inc.
05/15/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2023 SC 13G/A Lynx1 Capital Management LP reports a 9.7% stake in Cabaletta Bio, Inc.
02/14/2023 SC 13G/A Lynx1 Capital Management LP reports a 6.2% stake in Passage BIO, Inc.
02/14/2023 SC 13G/A Lynx1 Capital Management LP reports a 7.6% stake in Pieris Pharmaceuticals, Inc.
02/14/2023 SC 13G/A Lynx1 Capital Management LP reports a 6.8% stake in Alpine Immune Sciences, Inc.
02/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
01/23/2023 SC 13G Lynx1 Capital Management LP reports a 5% stake in Kinnate Biopharma Inc.
01/23/2023 SC 13G Lynx1 Capital Management LP reports a 5% stake in Neoleukin Therapeutics, Inc.
12/30/2022 SC 13G Lynx1 Capital Management LP reports a 5.4% stake in Neoleukin Therapeutics, Inc.
11/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
10/24/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/29/2022 SC 13G Lynx1 Capital Management LP reports a 5.1% stake in Passage BIO, Inc.
08/15/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/16/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
04/22/2022 SC 13G Lynx1 Capital Management LP reports a 5.1% stake in Alpine Immune Sciences, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy